SCHEMBL7964136

SCHEMBL7964136

Clc1cccc(C2CCN(CCCc3nnc4n3CCCCC4)CC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
DRD3 P35462 2/20 0.44
DRD2 P14416 1/20 0.44
DRD4 P21917 1/20 0.44
GRM2 Q14416 1/20 0.44
CHRM2 P08172 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA1D P25100 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
SLC6A4 P31645 1/20 0.43
ADRA1A P35348 1/20 0.43
HTR2B P41595 1/20 0.43
PKM P14618 1/20 0.43
POLB P06746 2/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957361 0.88 DRD2 (0.48) GAASMN1; SMN2DRD3DRD2CHRM2
Hydrochloric Acid SCHEMBL8570980 0.87 DRD2 (0.47) GAASMN1; SMN2DRD3DRD2CHRM2
SCHEMBL7959264 0.86 LMNA (0.53) GAASMN1; SMN2DRD3DRD2CHRM2
SCHEMBL7959555 0.84 LMNA (0.46) GAASMN1; SMN2DRD3DRD2CHRM2
SCHEMBL7964092 0.84 PKM (0.53) GAASMN1; SMN2DRD3DRD2CHRM2
SCHEMBL7963490 0.84 LMNA (0.46) GAASMN1; SMN2DRD3DRD2CHRM2
SCHEMBL7959711 0.84 SLC6A4 (0.51) GAASMN1; SMN2DRD3DRD2CHRM2
SCHEMBL7959422 0.82 DRD2 (0.44) GAASMN1; SMN2DRD3DRD2GRM2
SCHEMBL7961353 0.82 HTR1A (0.47) GAASMN1; SMN2DRD3DRD2CHRM2
SCHEMBL7957315 0.81 LMNA (0.51) DRD3DRD2CHRM2HTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed